Hair loss is rarely a single-cause condition. The follicle is a miniature organ that cycles through growth, regression, rest, and shedding phases on its own clock. When that clock is disrupted (by hormones, nutrition, inflammation, or mechanical stress), the result is visible thinning. Each mechanism below has a published trichology pathway and is addressable with the right topical strategy.
The hair growth cycle and its disruption
Every scalp follicle moves through four phases. Anagen is active growth and lasts two to seven years; this phase determines maximum hair length and accounts for roughly 85% of follicles at any given time. Catagen is a brief two-to-three-week regression where the follicle base contracts. Telogen is a three-to-four-month resting phase, occupying about 10–15% of follicles. Exogen is the active shedding phase: the old hair releases as a new anagen hair pushes up beneath it. The healthy scalp loses 50–100 hairs per day as a normal part of this cycle.
Pathological shedding occurs when one of three things happens. First, the proportion of follicles in telogen rises sharply. This is telogen effluvium, where a triggering event (illness, surgery, weight loss, postpartum hormone shift) pushes anagen follicles into telogen prematurely. Two to four months later, those follicles enter exogen all at once and the patient notices handfuls of hair in the shower. Second, anagen duration shortens progressively, so each new hair grows shorter and finer than the last. This is the miniaturisation seen in androgenetic alopecia. Third, the follicle is mechanically damaged or the hair shaft itself breaks before reaching exogen: traction alopecia and chemical-process breakage. Knowing which pattern is at work is the first step in any meaningful intervention.
Androgenetic alopecia and DHT
Androgenetic alopecia is the genetically inherited, hormone-mediated thinning that produces classic male pattern (frontal recession plus vertex thinning) and female pattern (diffuse central thinning preserving the frontal hairline). The mechanism centres on dihydrotestosterone, or DHT: the more potent metabolite of testosterone, produced locally in the scalp by the enzyme 5-alpha-reductase. DHT binds to androgen receptors on susceptible follicles and triggers progressive miniaturisation: each new growth cycle produces a shorter, finer, less pigmented hair until the follicle eventually goes dormant.
Susceptibility is genetic and is inherited polygenically, not from a single Y-chromosome locus, despite the persistent myth. The androgen receptor density on scalp follicles, the activity of local 5-alpha-reductase, and the threshold at which the follicle responds to DHT all vary by family. This is why oral 5-alpha-reductase inhibitors (finasteride, dutasteride) and topical anti-androgens slow but rarely reverse the process: they reduce the DHT signal, but the underlying receptor sensitivity remains. Procapil, an in-vitro proven combination of biotinyl-tripeptide, oleanolic acid, and apigenin, targets the same pathway through three mechanisms: improved peri-follicular microcirculation, reduced 5-alpha-reductase activity, and strengthened follicle anchoring at the dermal papilla. Caffeine acts as a complementary mild 5-alpha-reductase inhibitor with documented penetration to the follicle bed.
Telogen effluvium — stress, nutrition, postpartum
Telogen effluvium is the diffuse, reactive form of hair loss. It is not patterned and does not produce miniaturisation. Instead, anagen follicles are pushed prematurely into telogen by a systemic trigger. Common triggers include high fever, surgery under general anaesthesia, rapid weight loss (more than 5 kg in two months), iron deficiency, vitamin D deficiency, thyroid dysfunction, postpartum hormone fluctuation, and severe psychological stress sustained for weeks or months.
The shedding peaks two to four months after the trigger, which is why the cause is so often missed in clinic. By the time the patient presents with handfuls of hair, the original event has receded from memory. The good news is that telogen effluvium is reversible: once the trigger resolves, follicles re-enter anagen on their normal schedule and full density typically returns within twelve to eighteen months. The intervention window is limited to supporting the scalp environment and the new anagen hairs as they emerge: that means biotin, zinc, and amino acid support, gentle cleansing, and avoiding compounding stressors like aggressive heat styling. For postpartum effluvium specifically, the typical course runs two to six months and resolves spontaneously in roughly 90% of cases.